1. The mechanism of the inhibitory action of presynaptic muscarinic receptors on the release of acetylcholine from striatal cholinergic neurons is not known. We investigated how the electrically stimulated release of [3H]-acetylcholine from superfused rat striatal slices and its inhibition by carbachol are affected by specific inhibitors of voltage-operated calcium channels of the L-type (nifedipine), N-type (omega-conotoxin GVIA) and P/Q-type (omega-agatoxin IVA). 2. The evoked release of [3H]-acetylcholine was not diminished by nifedipine but was lowered by omega-conotoxin GVIA and by omega-agatoxin IVA, indicating that both the N- and the P/Q-type (but not the L-type) channels are involved in the release. The N-type channels were responsible for approximately two thirds of the release. The release was >97% blocked when both omega-toxins acted together. 3. The inhibition of [3H]-acetylcholine release by carbachol was not substantially affected by the blockade of the L- or P/Q-type channels. It was diminished but not eliminated by the blockade of the N-type channels. 4. In experiments on slices in which cholinesterases had been inhibited by paraoxon, inhibition of [3H]-acetylcholine release by endogenous acetylcholine accumulating in the tissue could be demonstrated by the enhancement of the release after the addition of atropine. The inhibition was higher in slices with functional N-type than with functional P/Q-type channels. 5. We conclude that both the N- and the P/Q-type calcium channels contribute to the stimulation-evoked release of acetylcholine in rat striatum, that the quantitative contribution of the N-type channels is higher, and that the inhibitory muscarinic receptors are more closely coupled with the N-type than with the P/Q-type calcium channels.

Institute of Physiology Academy of Sciences Vídenská 1083 14220 Prague Czechia

Zobrazit více v PubMed

ADAMS M.E., MYERS R.A., IMPERIAL J.S., OLIVERA B.M. Toxityping rat brain calcium channels with gamma-toxins from spider and cone snail venoms. Biochemistry. 1993;32:12566–12570. PubMed

BOEHM S., HUCK S. Inhibition of N-type calcium channels. The only mechanism by which presynaptic alpha(2)-autoreceptors control sympathetic transmitter release. Eur. J. Neurosci. 1996;8:1924–1931. PubMed

COUSIN M.A., HURST H., NICHOLLS D.G. Presynaptic calcium channels and field-evoked transmitter exocytosis from cultured cerebellar granule cells. Neuroscience. 1997;81:151–161. PubMed

CUNNINGHAM S.M., MIHARA S., HIGASHI H. Presynaptic calcium channels mediating synaptic transmission in submucosal neurones of the guinea-pig caecum. J. Physiol. Lond. 1998;509:425–435. PubMed PMC

DELMAS P., BROWN D.A., DAYRELL M., ABOGADIE F.C., CAULFIELD M.P., BUCKLEY N.J. On the role of endogenous G-protein βγ subunits in N-type Ca2+ current inhibition by neurotransmitters in rat sympathetic neurones. J. Physiol. London. 1998;506:319–329. PubMed PMC

DOLEžAL V., HUANG H.Y., SCHOBERT A., HERTTING G. 3,4-Diaminopyridine masks the inhibition of noradrenaline release from chick sympathetic neurons via presynaptic α2-adrenoceptors: insights into the role of N- and L-type calcium channels. Brain Res. 1996;721:101–110. PubMed

DOLEžAL V., JACKISCH R., HERTTING G., ALLGAIER C. Activation of dopamine D1 receptors does not affect D2 receptor-mediated inhibition of acetylcholine release in rabbit striatum. Naunyn-Schmiedeberg's Arch. Pharmacol. 1992;345:16–20. PubMed

DOLEžAL V., TUčEK S. Failure of the calcium channel activator, Bay K 8644, to increase the release of acetylcholine from nerve terminals in brain and diaphragm. Br. J. Pharmacol. 1987;91:475–479. PubMed PMC

DOLEžAL V., TUčEK S. Effects of atropine on the release of newly synthesized acetylcholine from rat striatal slices at various concentrations of calcium ions. Neurochem. Res. 1990;15:41–45. PubMed

DOLEžAL V., TUčEK S. The effects of brucine and alcuronium on the inhibition of [3H]acetylcholine release from rat striatum by muscarinic receptor agonists. Br. J. Pharmacol. 1998;124:1213–1218. PubMed PMC

DOLEžAL V., TUčEK S., HYNIE S. Effects of pertussis toxin suggest a role for G-proteins in the inhibition of acetylcholine release from rat myenteric plexus by opioid and presynaptic muscarinic receptors. Eur. J. Neurosci. 1989;1:127–131. PubMed

DOLEžAL V., WECKER L. Muscarinic receptor blockade increases basal acetylcholine release from striatal slices. J. Pharmacol. Exp. Ther. 1990;252:739–743. PubMed

DOLPHIN A.C. Voltage-dependent calcium channels and their modulation by neurotransmitters and G proteins. Exp. Physiol. 1995;80:1–36. PubMed

DOLPHIN A.C. Mechanisms of modulation of voltage-dependent calcium channels by G proteins. J. Physiol. London. 1998;506:3–11. PubMed PMC

DOROSHENKO P.A., WOPPMANN A., MILJANICH G., AUGUSTINE G.J. Pharmacologically distinct presynaptic calcium channels in cerebellar excitatory and inhibitory synapses. Neuropharmacology. 1997;36:865–872. PubMed

DOUGHTY J.M., BARNES D., RUSZNAK Z., HARASZTOSI C., FORSYTHE I.D. Contrasting Ca2+ channel subtypes at cell bodies and synaptic terminals of rat anterioventral cochlear bushy neurones. J. Physiol. 1998;512:365–376. PubMed PMC

DRUKARCH B., SCHEPENS E., STOOF J.C. Muscarinic receptor activation attenuates D2 dopamine receptor mediated inhibition of acetylcholine release in rat striatum: indications for a common signal transduction pathway. Neuroscience. 1990;37:1–9. PubMed

DUNLAP K., LUEBKE J.I., TURNER T.J. Exocytotic Ca2+ channels in mammalian central neurons. Trends Neurosci. 1995;18:89–98. PubMed

HAYDON P.G., TRUDEAU L.-G. Regulatory roles for GTP-binding proteins in nerve terminals. Seminars Neurosci. 1998;9:220–231.

HERLITZE S., GARCIA D.E., MACKIE K., HILLE B., SCHEUER T., CATTERALL W.A. Modulation of Ca2+ channels by G-protein beta gamma subunits. Nature. 1996;380:258–262. PubMed

HILLYARD D.R., MONJE V.D., MINTZ I.M., BEAN B.P., NADASDI L, , RAMACHANDRAN J., MILJANICH G., AZIMI ZOONOOZ A., MCINTOSH J.M., CRUZ L.J., IMPERIAL J.S., OLIVERA B.M. A new Conus peptide ligand for mammalian presynaptic Ca2+ channels. Neuron. 1992;9:69–77. PubMed

IKEDA S.R. Voltage-dependent modulation of N-type calcium channels by G-protein beta gamma subunits. Nature. 1996;380:255–258. PubMed

KATZ E., PROTTI D.A., FERRO P.A., SIRI M.D.R., UCHITEL O.D. Effects of Ca2+ channel blocker neurotoxins on transmitter release and presynaptic currents at the mouse neuromuscular junction. Br. J. Pharmacol. 1997;121:1531–1540. PubMed PMC

KAZDA S., KNORR A.Calcium antagonists Handbook of Experimental Pharmacology, Vol. 93, Pharmacology of Antihypertensive Therapeutics 1990Berlin: Springer-Verlag; 301–375.ed. Ganten D. & Mulrow P.J. pp

KOH D.S., HILLE B. Modulation by neurotransmitters of catecholamine secretion from sympathetic ganglion neurons detected by amperometry. Proc. Natl. Acad. Sci. U.S.A. 1997;94:1506–1511. PubMed PMC

LEVEQUE C., EL FAR O., MARTIN-MOUTOT N., SATO K., KATO R., TAKAHASHI M., SEAGAR M.J. Purification of the N-type calcium channel associated with syntaxin and synaptotagmin. A complex implicated in synaptic vesicle exocytosis. J. Biol. Chem. 1994;269:6306–6312. PubMed

LUEBKE J.I., DUNLAP K., TURNER T.J. Multiple calcium channel types control glutamatergic synaptic transmission in the hippocampus. Neuron. 1993;11:895–902. PubMed

MCDONOUGH S.I., SWARTZ K.J., MINTZ I.M., BOLAND L.M., BEAN B.P. Inhibition of calcium channels in rat central and peripheral neurons by omega-conotoxin MVIIC. J. Neurosci. 1996;16:2612–2623. PubMed PMC

MILJANICH G.P., RAMACHANDRAN J. Antagonists of neuronal calcium channels: Structure, function, and therapeutic implications. Annu. Rev. Pharmacol. Toxicol. 1995;35:707–734. PubMed

MILLER R.J. Presynaptic receptors. Annu. Rev. Pharmacol. Toxicol. 1998;38:201–227. PubMed

MINTZ I.M., ADAMS M.E., BEAN B.P. P-type calcium channels in rat central and peripheral neurons. Neuron. 1992;9:85–95. PubMed

MOCHIDA S., SHENG Z.H., BAKER C., KOBAYASHI H., CATTERALL W.A. Inhibition of neurotransmission by peptides containing the synaptic protein interaction site of N-type Ca2+ channels. Neuron. 1996;17:781–788. PubMed

OLIVERA B.M., MILJANICH G.P., RAMACHANDRAN J., ADAMS M.E. Calcium channel diversity and neurotransmitter release: The omega-conotoxins and omega-agatoxins. Annu. Rev. Biochem. 1994;63:823–867. PubMed

PROTTI D.A., UCHITEL O.D. Transmitter release of presynaptic Ca2+ currents blocked by the spider toxin ω-agatoxin-IVA. Neuroreport. 1993;5:333–336. PubMed

QIAN J., SAGGAU P. Presynaptic inhibition of synaptic transmission in the rat hippocampus by activation of muscarinic receptors: involvement of presynaptic calcium influx. Brit. J. Pharmacol. 1997;122:511–519. PubMed PMC

RANDALL A., TSIEN R.W. Pharmacological dissection of multiple types of Ca2+ channel currents in rat cerebellar granule neurons. J. Neurosci. 1995;15:2995–3012. PubMed PMC

SATHER W.A., TANABE T., ZHANG J.-F., MORI Y., ADAMS M.E., TSIEN R.W. Distinctive biophysical and pharmacological properties of class A (B1) calcium channel alpha1 subunits. Neuron. 1993;11:291–303. PubMed

SMITH A.B., CUNNANE T.C. Multiple calcium channels control neurotransmitter release from rat postganglionic sympathetic nerve terminals. J. Physiol. London. 1997;499:341–349. PubMed PMC

STANLEY E.E. The calcium channel and the organization of the presynaptic transmitter release face. Trends Neurosci. 1997;20:404–409. PubMed

TAREILUS E., BREER H. Presynaptic calcium channels: Pharmacology and regulation. Neurochem. Int. 1995;26:539–558. PubMed

TURNER T.J., ADAMS M.E., DUNLAP K. Multiple Ca2+ channel types coexist to regulate synaptosomal neurotransmitter release. Proc. Natl. Acad. Sci. U.S.A. 1993;90:9518–9522. PubMed PMC

UCHITEL O.D. Toxins affecting calcium channels in neurons. Toxicon. 1997;35:1161–1191. PubMed

WESSLER I., DOOLEY D.J., WERHAND J., SCHLEMMER F. Differential effects of calcium channel antagonists (gamma-conotoxin GVIA, nifedipine, verapamil) on the electrically-evoked release of [3H]acetylcholine from the myenteric plexus, phrenic nerve and neocortex of rats. Naunyn-Schmiedeberg's Arch. Pharmacol. 1990;341:288–294. PubMed

WILLIAMS M.E., FELDMAN D.H., MCCUE A.F., BRENNER R., VELICELEBI G, , ELLIS S.B., HARPOLD M.M. Structure and functional expression of α1, α2, and β subunits of a novel human neuronal calcium channel subtype. Neuron. 1992;8:71–84. PubMed

WU L.-G., SAGGAU P. Pharmacological identification of two types of presynaptic voltage-dependent calcium channels at CA3-CA1 synapses of the hippocampus. J. Neurosci. 1994a;14:5613–5622. PubMed PMC

WU L.-G., SAGGAU P. Adenosine inhibits evoked synaptic transmission primarily by reducing presynaptic calcium influx in area CA1 of hippocampus. Neuron. 1994b;12:1139–1148. PubMed

WU L.-G., SAGGAU P. Presynaptic inhibition of elicited neurotransmitter release. Trends Neurosci. 1997;20:204–212. PubMed

WU L.-G., WESTENBROEK R.E., BORST J.G.G., CATTERALL W.A., SAKMANN B. Calcium channel types with distinct presynaptic localization couple differentially to transmitter release in single calyx-type synapses. J. Neurosci. 1999;19:726–736. PubMed PMC

YAN Z., SONG W.J., SURMEIER J. D2 dopamine receptors reduce N-type Ca2+ currents in rat neostriatal cholinergic interneurons through a membrane-delimited, protein-kinase-C-insensitive pathway. J. Neurophysiol. 1997;77:1003–1015. PubMed

YAN Z., SURMEIER D.J. Muscarinic (m2/m4) receptors reduce N- and P-type Ca2+ currents in rat neostriatal cholinergic interneurons through a fast, membrane-delimited, G-protein pathway. J. Neurosci. 1996;16:2592–2604. PubMed PMC

Chronic exposure of NG108-15 cells to amyloid beta peptide (A beta(1-42)) abolishes calcium influx via N-type calcium channels